Use of anti-EGFR agents among elderly patients with metastatic colorectal cancer (mCRC).

被引：0

作者：

D'Silva, Ashley James

Dotan, Efrat

Kloth, Dwight D.

Beck, Andrew

Cohen, Steven J.

Denlinger, Crystal Shereen

机构：

[1] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA

[2] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期

关键词：

D O I：

10.1200/jco.2012.30.4_suppl.657

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

657

引用

页数：2

共 50 条

[41] Identifying prognostic subgroups for outcomes in wild-type RAS metastatic colorectal cancer (mCRC) treated with anti-EGFR drugs [J].

Vladimirova, L. ;

Kit, O. ;

Abramova, N. ;

Storozhakova, A. ;

Popova, I. ;

Tikhanovskaya, N. ;

Ezhova, M. .

ANNALS OF ONCOLOGY, 2017, 28

[42] Liquid biopsy-driven anti-EGFR rechallenge in patients with metastatic colorectal cancer. [J].

Mariani, Stefano ;

Puzzoni, Marco ;

Liscia, Nicole ;

Impera, Valentino ;

Pretta, Andrea ;

Tolu, Simona ;

Pireddu, Anna Grazia ;

Persano, Mara ;

Musio, Francesca ;

Donisi, Clelia ;

Pinna, Giovanna ;

Lai, Eleonora ;

Demurtas, Laura ;

Ziranu, Pina ;

Pusceddu, Valeria ;

Pisano, Marina ;

Palomba, Grazia ;

Casula, Milena ;

Palmieri, Giuseppe ;

Scartozzi, Mario .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

[43] Nanofluidic digital PCR for improved selection of metastatic colorectal cancer patients to anti-EGFR therapies [J].

Azuara, D. ;

Santos, C. ;

Lopez-Doriga, A. ;

Montal, R. ;

Sanjuan, X. ;

Moreno, V. ;

Tabernero, J. ;

Montagut, C. ;

Salazar, R. ;

Capella, G. .

EUROPEAN JOURNAL OF CANCER, 2013, 49 :S154-S155

[44] Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response [J].

Liu, X. ;

George, G. C. ;

Tsimberidou, A. M. ;

Naing, A. ;

Wheler, J. J. ;

Kopetz, S. ;

Fu, S. ;

Piha-Paul, S. A. ;

Eng, C. ;

Falchook, G. S. ;

Janku, F. ;

Garrett, C. ;

Karp, D. ;

Kurzrock, R. ;

Zinner, R. ;

Raghav, K. ;

Subbiah, V. ;

Hess, K. ;

Meric-Bernstam, F. ;

Hong, D. S. ;

Overman, M. J. .

BMC CANCER, 2015, 15

[45] Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients: A Multi-institutional Analysis [J].

Rossini, Daniele ;

Germani, Marco Maria ;

Pagani, Filippo ;

Pellino, Antonio ;

Dell'Aquila, Emanuela ;

Bensi, Maria ;

Liscia, Nicole ;

Moretto, Roberto ;

Boccaccino, Alessandra ;

Prisciandaro, Michele ;

Manglaviti, Sara ;

Schirripa, Marta ;

Vivolo, Raffaella ;

Scartozzi, Mario ;

Santini, Daniele ;

Salvatore, Lisa ;

Pietrantonio, Filippo ;

Loupakis, Fotios ;

Falcone, Alfredo ;

Cremolini, Chiara .

CLINICAL COLORECTAL CANCER, 2020, 19 (03) :191-+

[46] Efficacy of combinations of BRAF inhibitors and anti-EGFR antibodies in metastatic colorectal carcinoma (mCRC) patients with mBRAF in the real clinical practice [J].

Fedyanin, M. ;

Elsnukaeva, H. ;

Demidova, I. ;

Stroyakovskiy, D. ;

Shelygin, Y. ;

Tsukanov, A. ;

Panina, M. ;

Moiseenko, F. ;

Karpenko, E. ;

Bolotina, L. ;

Kudryavtseva, A. ;

Filipenko, M. ;

Oskorbin, I. ;

Vladimirova, L. Y. ;

Timoshkina, N. N. ;

Kit, O. I. ;

Stroganova, A. ;

Dranko, S. ;

Tryakin, A. ;

Tjulandin, S. .

ANNALS OF ONCOLOGY, 2021, 32 :S557-S558

[47] Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response [J].

X. Liu ;

G. C. George ;

A. M. Tsimberidou ;

A. Naing ;

J. J. Wheler ;

S. Kopetz ;

S. Fu ;

S. A. Piha-Paul ;

C. Eng ;

G. S. Falchook ;

F. Janku ;

C. Garrett ;

D. Karp ;

R. Kurzrock ;

R. Zinner ;

K. Raghav ;

V. Subbiah ;

K. Hess ;

F. Meric-Bernstam ;

D. S. Hong ;

M. J. Overman .

BMC Cancer, 15

[48] Prediction of response to anti-EGFR antibocies in metastatic colorectal cancer: looking beyond EGFR inhibition [J].

Ottaiano, Alessandro ;

Capuozzo, Maurizio ;

Nasti, Guglielmo ;

Maiolino, Piera ;

De Angelis, Valentina ;

Scala, Stefania ;

Iaffaioli, Rosario V. .

FRONTIERS IN IMMUNOLOGY, 2013, 3

[49] Hsa-miR-31-3p expression in FFPE tumor samples as a predictor of anti-EGFR response in patients with metastatic colorectal cancer (mCRC) [J].

Manceau, G. ;

Imbeaud, S. ;

Mosakhani, N. ;

Thiebaut, R. ;

Liebaert, F. ;

Van Laethem, J. L. ;

Demetter, P. ;

Chibaudel, B. ;

Andre, T. ;

Laurent-Puig, P. .

EUROPEAN JOURNAL OF CANCER, 2013, 49 :S563-S563

[50] RAS mutations in circulating tumor DNA (ctDNA) and clinical outcomes of rechallenge treatments with anti-EGFR antibodies n patients with metastatic colorectal cancer (mCRC) [J].

Sunakawa, Y. ;

Nakamura, M. ;

Ishizaki, M. ;

Kataoka, M. ;

Satake, H. ;

Kitazono, M. ;

Yanagisawa, H. ;

Kawamoto, Y. ;

Kuramochi, H. ;

Ohori, H. ;

Nakamura, M. ;

Takahashi, K. ;

Maeda, F. ;

Komeno, C. ;

Takeuchi, M. ;

Fujii, M. ;

Yoshino, T. ;

Ichikawa, W. ;

Tsuji, A. .

ANNALS OF ONCOLOGY, 2019, 30 :114-114

← 1 2 3 4 5 →